Intrathecal endomorphin-1 produces antinociceptive activities modulated by alpha 2-adrenoceptors in the rat tail flick, tail pressure and formalin tests

Life Sciences

Volumn 66, Issue 15, 2000, Pages 195-204

  Hao, Shuanglin ^a   Takahata, Osamu ^a   Iwasaki, Hiroshi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Alpha 2 adrenoceptor; Endomorphin 1; Formalin tests; Rat; Tail flick; Tail pressure

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ENDOMORPHIN 1; MU OPIATE RECEPTOR; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; IMMUNOREACTIVITY; MALE; NONHUMAN; PRESSURE; RAT; RECEPTOR INTRINSIC ACTIVITY; SPINAL REFLEX; TAIL FLICK TEST;

ANIMALIA;

EID: 0034599150     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00457-4     Document Type: Article

References (23)

1. J.E. Zadina, L. Hackler, L.J. Ge and A.J. Kastin, Nature. 386 499-502 (1997).
2. S.Y. Wu, S.L. Dun, M.T. Wright, J.K. Chang and N.J. Dun, Neuroscience. 89 317-321 (1999).
3. L.S. Stone, C.A. Fairbanks, T.M. Laughlin, H.O. Nguyen, T.M. Bushy, M.W. Wessendorf and G.L. Wilcox, Neuroreport. 8 3131-3135 (1997).
4. B. Przewlocka, J. Mika, D. Labuz, G. Toth, and R. Przewlocki, Eur. J. Pharmacol. 367 189-196 (1999).
5. A.F. Sullivan, M.R. Dashwood and A.H. Dickenson, Eur. J. Pharmacol. 138 169-177 (1987).
6. G.L. Wilcox, K.H. Carlsson, A. Jochim and I. Jurna, Brain Res. 405 84-93 (1987).
7. T. Crisp, J.L. Stafinsky, J.E. Hess and M. Uram, Eur. J. Pharmacol. 160 211-217 (1989).
8. S. Irwin, R.W. Houde, D.D. Bennet, L.C. Hendershot and M.H. Seevers, J. Pharmaco. Exp. Ther. 101 132-143 (1951).
9. T. Sato, S. Sakurada, N. Takahashi, T. Sakurada, K. Tan-No, K. Wako and K. Kisara, Eur. J. Pharmacol. 369 183-187 (1999).
10. Y. Kuraishi, Y. Harada, S. Aratani, M. Satoh and H. Takagi, Brain Res. 273 245-252 (1983)
11. T.L. Yaksh and T.A. Rudy, Science. 192 1357-1358 (1976).
12. D.P. Archer, A. Ewen, S.H. Roth and N. Samanani, Anesthesiology. 80 168-176 (1994).
13. S. Hao and H. Ogawa, Neuroscience Lett. 248 124-126 (1998).
14. I.E. Goldberg, G.C. Rossi, S.R. Letchworth, J.P. Mathis, J. Ryan-Moro, L. Leventhal, W. Su, D. Emmel, E.A. Bolan and G.W. Paskernak, J. Pharmaco. Exp. Ther. 286 1007-1013 (1998).
15. C.G. Heapy, A. Jamieson and N.J.W. Russell, Br. J. Pharmac. 90 164P (1987).
16. V. Chapman, A. Diaz and A.H. Dickenson, Br. J. Pharmacol. 122 1537-1539 (1997).
17. S. Wigdor and G.L. Wilcox, J. Pharmaco. Exp. Ther. 242 90-95 (1987).
18. K.A. Gergen, J.E. Zadina, A.J. Kastin and D. Paul, Eur. J. Pharmacol. 298 235-239 (1996).
19. J.L. Hylden and G.L. Wilcox, J. Pharmaco. Exp. Ther. 226 398-404 (1983)
20. K. Drasner and H.L. Fields, Pain. 32 309-312 (1988).
21. K. Przesmycki, J.A. Dzieciuch, S.J. Czuczwar and Z. Kleinrok, Eur. J. Pharmaco. 337 11-17 (1997).
22. R.E. Solomon and G.F. Gebhart, J. Pharmaco. Exp. Ther. 245 444-454 (1988)
23. C.W. Stevens, M.S. Monasky and T.L. Yaksh, J. Pharmaco. Exp. Ther. 244 63-70 (1988)